Ulka N. Vaishampayan
- Pulmonary and Respiratory Medicine top 0.1%
- Oncology top 0.2%
- Molecular Biology top 1%
- Cancer Research top 0.2%
- Surgery top 1%
- Co-authors
- Toni K. ChoueiriBrian I. RiniMaha HussainGeorg A. BjarnasonDaniel Y.C. HengFrede DonskovLori WoodDavid F. McDermott
- Topics
- Renal cell carcinoma treatment (185 papers)Prostate Cancer Treatment and Research (114 papers)Cancer Immunotherapy and Biomarkers (98 papers)
- Journals
- The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ulka N. Vaishampayan
471 papers receiving 12.6k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Pulmonary and Respiratory Medicine 7.3k
- Oncology 5.7k
- Molecular Biology 5.0k
- Cancer Research 3.1k
- Surgery 2.8k
Countries citing papers authored by Ulka N. Vaishampayan
This map shows the geographic impact of Ulka N. Vaishampayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulka N. Vaishampayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulka N. Vaishampayan more than expected).
Fields of papers citing papers by Ulka N. Vaishampayan
This network shows the impact of papers produced by Ulka N. Vaishampayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulka N. Vaishampayan. The network helps show where Ulka N. Vaishampayan may publish in the future.
Co-authorship network of co-authors of Ulka N. Vaishampayan
This figure shows the co-authorship network connecting the top 25 collaborators of Ulka N. Vaishampayan. A scholar is included among the top collaborators of Ulka N. Vaishampayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulka N. Vaishampayan. Ulka N. Vaishampayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 14 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 7 | |
| 9 | 1 | |
| 10 | 21 | |
| 11 | 22 | |
| 12 | 10 | |
| 13 | 18 | |
| 14 | 16 | |
| 15 | 2 | |
| 16 | 22 | |
| 17 | 26 | |
| 18 | 3 | |
| 19 | 11 | |
| 20 | Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trialbreakdown → | 865 |
About Ulka N. Vaishampayan
Ulka N. Vaishampayan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 495 papers that have together received 12.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (185 papers), Prostate Cancer Treatment and Research (114 papers) and Cancer Immunotherapy and Biomarkers (98 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.3k citations), Oncology (5.7k citations) and Cancer Research (3.1k citations). Ulka N. Vaishampayan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Toni K. Choueiri, Brian I. Rini, Maha Hussain, Georg A. Bjarnason, Daniel Y.C. Heng, Frede Donskov, Lori Wood, David F. McDermott, Sumanta K. Pal and Neeraj Agarwal. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.